Renal Denervation
Renal Denervation is a medical device with 57 clinical trials. Currently 9 active trials ongoing. Historical success rate of 67.9%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
6
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
63.3%
19 of 30 finished
36.7%
11 ended early
9
trials recruiting
57
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Renal Denervation Combined With Pulsed Field Ablation to Prevent Recurrence in Persistent Atrial Fibrillation
Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE
REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /
Renal Denervation in ADPKD- RDN-ADPKD Study
Clinical Trials (57)
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Renal Denervation Combined With Pulsed Field Ablation to Prevent Recurrence in Persistent Atrial Fibrillation
Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE
REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /
Renal Denervation in ADPKD- RDN-ADPKD Study
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
RDN for Heart Failure
The Long-term Safety and Effect of Renal Denervation
Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension
Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis
Renal Arterial Denervation in Sympathetic Dysautonomia
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation
Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction
RADIANCE Continued Access Protocol
DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications
Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease
Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 57